GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » EBITDA Margin %

Hoechst Pakistan (KAR:HPL) EBITDA Margin % : 12.16% (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hoechst Pakistan's EBITDA for the three months ended in Mar. 2024 was ₨765 Mil. Hoechst Pakistan's Revenue for the three months ended in Mar. 2024 was ₨6,287 Mil. Therefore, Hoechst Pakistan's EBITDA margin for the quarter that ended in Mar. 2024 was 12.16%.


Hoechst Pakistan EBITDA Margin % Historical Data

The historical data trend for Hoechst Pakistan's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoechst Pakistan EBITDA Margin % Chart

Hoechst Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.63 9.03 11.21 5.57 6.12

Hoechst Pakistan Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.19 1.62 11.56 11.90 12.16

Competitive Comparison of Hoechst Pakistan's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Hoechst Pakistan's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hoechst Pakistan's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hoechst Pakistan's EBITDA Margin % falls into.



Hoechst Pakistan EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hoechst Pakistan's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1308.184/21368.949
=6.12 %

Hoechst Pakistan's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=764.682/6287.309
=12.16 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoechst Pakistan  (KAR:HPL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hoechst Pakistan EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hoechst Pakistan's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoechst Pakistan (KAR:HPL) Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd Formerly Sanofi-Aventis Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines. Its product profile includes Oral Anti-Diabetics, Emergency Care, Antibiotics, Anti-malaria, Epilepsy, Sleep Disorders, and others. Geographically, the company operates in Pakistan, Afghanistan, and others.

Hoechst Pakistan (KAR:HPL) Headlines

No Headlines